1 / 19

Wirusowe Zapalenie Wątroby typu B /WZW B/ - etiologia, diagnostyka, profilaktyka.

Wirusowe Zapalenie Wątroby typu B /WZW B/ - etiologia, diagnostyka, profilaktyka. Dr n.med. Witold Wrodycki Klinika Chorób Zakaźnych i Hepatologii UM w Łodzi.

shellij
Download Presentation

Wirusowe Zapalenie Wątroby typu B /WZW B/ - etiologia, diagnostyka, profilaktyka.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Wirusowe Zapalenie Wątroby typu B /WZW B/ - etiologia, diagnostyka, profilaktyka. Dr n.med. Witold Wrodycki Klinika Chorób Zakaźnych i Hepatologii UM w Łodzi

  2. Wirusowe Zapalenia Wątroby – etiologia:A.wirusy pierwotnie hepatotropowe: 1. WZW A (HAV)2. WZW B (HBV)3. WZW C (HCV)4. WZW D (HDV, koinfekcja z HBV)5. WZW E (HEV) B. wirusy o wtórnym hepatotropizmie: EBV, CMV, VZV (HHV3), HSV (HHV-1, HHV-2)

  3. Hepatitis B Virus

  4. Epidemiologia HBV • Ponad 400 mln zakażonych na świecie • 1,25 mln zakażonych w USA • Nosicielstwo HBsAg na świecie od 1-20% • W Polsce nosicielstwo HBsAg - ok. 1-2 % • Spadek liczby zakażonych od 1990r (szczepienia p/wzw B) 1..1....... ...., m m

  5. Geographic Distribution of Chronic HBV Infection HBsAg Prevalence ³8% = High 2%-7% = Intermediate <2% = Low

  6. Wirusowe zapalenie wątroby (hepatitis virusalis) 1961 – 57 088 przyp. zgony 102, 1970 – 70 355 przyp. zgony 369 2000 HAV 262 przyp. (25,5 % w wieku 0-14) zgony 0 HBV 2825 przyp.(10,3% w wieku 0-14) zgony 0 HCV 2086 przyp. (5,7 % w wieku 0-14) zgony 0 2011 WZW B 250 przyp.

  7. Schematyczna budowa HBV

  8. Drogi tranmisji HBV • Seksualna • Parenteralna • Perinatalna • Zarażenie (invasioductio) – pasożyty

  9. Riskw Factors for Acute Hepatitis B Epidemiologia zakażeń HBV-cd. Seksualna Injecting Drug Use (15%) Homosexual Activity (9%) Household Contact (2%) Health Care Employment (1%) Other (1%) * Includes sexual contact with acute cases, carriers, and multiple partners. CxDC Sentinel Counties Study of Viral Hepatitis.

  10. Hepatitis B – Clinical Features • Incubation period: Average 60–90 days Range 45–180 days • Clinical illness (jaundice): <5 yrs, <10% >5 yrs, 30%–50% • Acute case-fatality rate: 0.5%–1% • Chronic infection: <5 yrs, 30%–90% >5 yrs, 2%–10% • Premature mortality fromchronic liver disease: 15%–25%

  11. Hepatitis B – Diagnostic Tools Markers of the virus • HBV DNA • HBeAg • HBsAg Markers of liver damage • ALT • AST • Bilirubin Antibodies to the virus • Anti-HBc • Anti-HBe • Anti-HBs Severity of liver damage • Bilirubin • Albumin • Prothrombin time

  12. No viral markers HBsAg - HBeAg - HBV DNA- Never Been Exposed to Hepatitis B No immune response to the virus • Anti-HBc - • Anti-HBs - • Anti-HBe -

  13. Full complement of viral markers, all present for < 6 months HBsAg + HBeAg + HBV DNA+ Some immune response to the virus Anti-HBs- Anti-Hbe- Anti-HBc+ Acute Hepatitis B Evidence of acute infection • Anti-HBc IgM+

  14. Acute Hepatitis B Virus Infection withRecovery Typical Serologic Course Symptoms anti-HBe HBeAg Total anti-HBc Titer anti-HBs IgM anti-HBc HBsAg 0 4 8 12 16 24 28 32 52 100 20 36 Weeks after exposure

  15. Chronic Hepatitis B with Evidence of Viral Replication Some immune response to the virus • Anti-HBc + • Anti-HBs - • Anti-HBe - Full complement of viral markers, all present for >6 months • HBsAg + • HBeAg + • HBV DNA + No evidence of acute infection • Anti-HBc IgM-

  16. Progression to Chronic Hepatitis B Virus Infection Typical Serologic Course Acute (6 months) Chronic (years) HBeAg anti-HBe HBsAg Total anti-HBc Titer IgM anti-HBc 0 4 8 16 20 24 28 36 12 32 52 Years Weeks after exposure

  17. Koncentracja HBV w różnych płynach w ustrojowych Duża: krew osocze, sączące rany Średnia: nasienie, wydzielina pochowa, sączące rany Mała: mocz, kał, łzy, pot, pokarm

  18. Dziękuje za uwagę

More Related